![David Arthur](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Arthur
Algemeen Directeur bij SALARIUS PHARMACEUTICALS, INC.
Vermogen: 22 750 $ op 31-05-2024
Profiel
David J.
Arthur is currently the President, Chief Executive Officer & Director at Salarius Pharmaceuticals LLC since 2015 and at Salarius Pharmaceuticals, Inc. since 2019.
Previously, he worked as the Managing Director at Dacon Pharma LLC from 2012 to 2015.
Mr. Arthur holds an MBA from The Fuqua School of Business.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
11-04-2024 | 49 135 ( 1.03% ) | 22 750 $ | 31-05-2024 |
Actieve functies van David Arthur
Bedrijven | Functie | Begin |
---|---|---|
SALARIUS PHARMACEUTICALS, INC. | Algemeen Directeur | 19-07-2019 |
Salarius Pharmaceuticals LLC
![]() Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Algemeen Directeur | 01-11-2015 |
Eerdere bekende functies van David Arthur
Bedrijven | Functie | Einde |
---|---|---|
Dacon Pharma LLC | Corporate Officer/Principal | 01-10-2015 |
Opleiding van David Arthur
North Carolina State University | Undergraduate Degree |
The Fuqua School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SALARIUS PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Salarius Pharmaceuticals LLC
![]() Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Health Technology |
Dacon Pharma LLC |